We've found
184,457
clinical trials
We've found
184,457
clinical trials
Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Breast Cancer Clinical Trial
Updated: 9/20/2012
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
Status: Enrolling
Updated: 9/20/2012
Click here to add this to my saved trials

Click here to add this to my saved trials

Prostate Cancer Clinical Trial
Updated: 12/31/1969
177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Neurology Clinical Trial
Updated: 12/11/2017
International PFO Consortium
Status: Enrolling
Updated: 12/11/2017
Click here to add this to my saved trials

Cardiology / Vascular Diseases Clinical Trial
Updated: 1/8/2016
Examining Developmental Changes in Heart Contractions of Children With Congenital Heart Defects
Status: Enrolling
Updated: 1/8/2016
Click here to add this to my saved trials

Tobacco Use Disorder Clinical Trial
Updated: 9/19/2013
Computer-Assisted Stop-Smoking Program in Helping Doctors Counsel Patients Who Smoke Cigarettes
Status: Enrolling,
Phase
II
Updated: 9/19/2013
Click here to add this to my saved trials

Alzheimer's Disease Clinical Trial
Updated: 9/26/2017
Dominantly Inherited Alzheimer Network (DIAN)
Status: Enrolling
Updated: 9/26/2017
Click here to add this to my saved trials

Alzheimer's Disease Clinical Trial
Updated: 9/26/2017
Dominantly Inherited Alzheimer Network (DIAN)
Status: Enrolling
Updated: 9/26/2017
Click here to add this to my saved trials

Alzheimer's Disease Clinical Trial
Updated: 9/26/2017
Dominantly Inherited Alzheimer Network (DIAN)
Status: Enrolling
Updated: 9/26/2017
Click here to add this to my saved trials

Myeloma Clinical Trial
Updated: 4/24/2018
UARK 2008-03 Phase II Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy (No Prior Transplant)
Status: Enrolling,
Phase
II
Updated: 4/24/2018
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 10/7/2013
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Status: Enrolling,
Phase
II
Updated: 10/7/2013
Click here to add this to my saved trials

Adhesive Capsulitis Clinical Trial
Updated: 5/15/2013
Dynamic Splinting for Patients With Adhesive Capsulitis
Status: Enrolling
Updated: 5/15/2013
Click here to add this to my saved trials

Endocrinology, Psychiatry / Psychology Clinical Trial
Updated: 1/7/2016
Glycemic Control, Brain Structure and Cognition in Youth With Type 1 Diabetes (T1DM)
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials

Orthopedics / Podiatry Clinical Trial
Updated: 6/12/2012
Cartilage Autograft Implantation System (CAIS) for the Repair of Knee Cartilage Through Cartilage Regeneration
Status: Enrolling
Updated: 6/12/2012
Click here to add this to my saved trials

Orthopedics / Podiatry Clinical Trial
Updated: 6/12/2012
Cartilage Autograft Implantation System (CAIS) for the Repair of Knee Cartilage Through Cartilage Regeneration
Status: Enrolling
Updated: 6/12/2012
Click here to add this to my saved trials

Orthopedics / Podiatry Clinical Trial
Updated: 6/12/2012
Cartilage Autograft Implantation System (CAIS) for the Repair of Knee Cartilage Through Cartilage Regeneration
Status: Enrolling
Updated: 6/12/2012
Click here to add this to my saved trials

Soft Tissue Sarcomas Clinical Trial
Updated: 9/14/2012
Proton Chemoradiotherapy for High-Risk Soft Tissue Sarcomas
Status: Enrolling
Updated: 9/14/2012
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Brain and Central Nervous System Tumors Clinical Trial
Updated: 12/31/1969
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
